Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2CNS 1

Conditions

Prostatic Neoplasms 3Herpes Zoster 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Papillomavirus Infections 2Neoplasms 2Melanoma 2Lung Neoplasms 2Influenza, Human 2Glioblastoma 2Whooping Cough 1Waldenstrom Macroglobulinemia 1Tetanus 1Spondylitis, Ankylosing 1Psoriasis 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Glandular and Epithelial 1Multiple Myeloma 1Meningitis 1Medulloblastoma 1Hematologic Neoplasms 1Glioma 1Diphtheria 1Diabetes Mellitus, Insulin-Dependent, 12 1Crohn Disease 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1

Interventions

Ipilimumab 98pembrolizumab 84Nivolumab 82aldesleukin 51Cyclophosphamide 49Interleukin-2 38fludarabine phosphate 31Vemurafenib 31Dacarbazine 31dabrafenib 29trametinib 28Temozolomide 26fludarabine 25CTLA-4 Antigen 18Bevacizumab 18Radiosurgery 15Paclitaxel 15Carboplatin 14encorafenib 13binimetinib 13Introns 13talimogene laherparepvec 12Radiotherapy 12Interferon alpha-2 12spartalizumab 11cobimetinib 10atezolizumab 10sargramostim 9peginterferon alfa-2b 9montanide ISA 51 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Melanoma × Vaccines × Clear all
NCT03092453 2024-12-24

Dendritic Cell Vaccination in Patients With Advanced Melanoma

University of Pennsylvania

Phase 1 Completed
5 enrolled 10 charts
Dermatologic

Melanoma

NCT02431572 2020-04-28

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Massachusetts General Hospital

Phase NA Completed
11 enrolled 8 charts
CNSDermatologic

Brain Neoplasms, Glioblastoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡